Skip to Main

News

UT Southwestern breaks ground on $177M Radiation Oncology campus in Fort Worth

 

Ushering in a new era in cancer care in Fort Worth, UT Southwestern Medical Center broke ground today on a $177 million Radiation Oncology campus that will provide the most advanced therapies for patients of the nation’s 12th largest city.

Protein linked to immunotherapy resistance in kidney cancer

 

A protein identified by researchers at UT Southwestern Medical Center may drive resistance to immune checkpoint inhibitors, a widely used form of immunotherapy to treat cancer.

FDA-designated orphan drug could increase radiation efficacy in lung cancer

 

– An FDA-designated orphan drug that can target a key vulnerability in lung cancer shows promise in improving the efficacy of radiation treatments in preclinical models, according to a study by UT Southwestern Medical Center researchers.

Differences in survival persist despite access to cancer clinical trials

 

Black and Hispanic children with high-risk neuroblastoma experience worse survival outcomes than their white peers, even when treated in frontline clinical trials, according to a study led by a UT Southwestern Medical Center researcher.